MedTrace Logo

Treatment of Periodontal Intra-bony Defects With a Volume Stable Collagen Matrix or Deproteinized Bovine Bone Mineral With 10% Collagen

NCT06676826 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2025-10-06

No results posted yet for this study

Summary

To compare the healing of intrabony periodontal defects treated with either open flap debridement and a volume-stable collagen matrix (VCMX) or a deproteinized bovine bone mineral with 10% collagen. The results will shed light on the clinical potential of VCMX in regenerative periodontal surgery and help to develop new treatment strategies.

Conditions

  • Periodontal Diseases

Interventions

DEVICE

Infrabony defects will be filled with a volume-stable collagen matrix (VCMX)

Infrabony defects will be filled with a volume-stable collagen matrix

DEVICE

Infrabony defects will be filled treated with a deproteinized bovine bone mineral with 10% collagen

Infrabony defects will be filled with with a deproteinized bovine bone mineral with 10% collagen

Sponsors & Collaborators

  • University of Bern

    lead OTHER

Principal Investigators

  • Alexandra Stähli, MD · University of Bern

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-09-01
Primary Completion
2026-09-30
Completion
2027-12-30

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06676826 on ClinicalTrials.gov